ARG23730
Rabbit anti-Hamster IgG (H+L) antibody (HRP), pre-adsorbed
Rabbit anti-Hamster IgG (H+L) antibody (HRP), pre-adsorbed for ELISA,FLISA,Flow cytometry,IHC-Frozen sections,Western blot and Hamster
Publication6
Overview
| Product Description | HRP-conjugated Rabbit Polyclonal antibody recognizes Hamster IgG (H+L) |
|---|---|
| Tested Reactivity | Hm |
| Species Does Not React With | Ms, Rat |
| Tested Application | ELISA, FACS, FLISA, IHC-Fr, WB |
| Specificity | Reacts with the heavy and light chains of Armenian and Syrian hamster IgG as demonstrated by ELISA or FLISA. May also react with other species and with the light chains of other hamster immunoglobulins. Minimal cross reactivity with Mouse and Rat serum proteins. |
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Target Name | IgG (H+L) |
| Antigen Species | Hamster |
| Immunogen | Hamster IgG (H+L) |
| Conjugation | HRP |
Application Instructions
| Pre Adsorbed | Mouse and Rat serum proteins. May react with immunoglobulins from other species and the light chains of other hamster immunoglobulins. | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Application Suggestion |
|
||||||||||||
| Application Note | * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. |
Properties
| Form | Liquid |
|---|---|
| Purification | Affinity purification with immunogen. |
| Buffer | PBS (pH 7.4) and 50% Glycerol |
| Stabilizer | 50% Glycerol |
| Storage Instruction | Aliquot and store in the dark at 2-8°C. Keep protected from prolonged exposure to light. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. |
| Note | For laboratory research only, not for drug, diagnostic or other use. |
Specific References
Lipid nanoparticle-encapsulated DNA vaccine robustly induce superior immune responses to the mRNA vaccine in Syrian hamsters
ELISA /
Induction of Th1 and Th2 in the protection against SARS-CoV-2 through mucosal delivery of an adenovirus vaccine expressing an engineered spike protein
ELISA /
Furin and TMPRSS2 Resistant Spike Induces Robust Humoral and Cellular Immunity Against SARS-CoV-2 Lethal Infection
ELISA /
A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection
ELISA /
Low-Dose SARS-CoV-2 S-Trimer with an Emulsion Adjuvant Induced Th1-Biased Protective Immunity
ELISA /
DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsters.
ELISA /
